Status:
RECRUITING
Role of Tryptase Levels in Patients With Stable Coronary Artery Disease.
Lead Sponsor:
University of Thessaly
Conditions:
Chronic Coronary Syndrome
Eligibility:
All Genders
18-85 years
Brief Summary
The aim of this study is to measure the levels of serum tryptase and correlate them with the severity of coronary artery disease in study population. In addition, it will evaluate the usability of try...
Detailed Description
Coronary artery disease (CAD) is the leading cause of death worldwide based on WHO' s latest review in 2019 with CAD being responsible for the 16% of them. The main feature of coronary artery disease ...
Eligibility Criteria
Inclusion
- Male and female subjects aged 18 - 85 years old.
- Clinical symptoms of angina which are classified based on the Canadian Cardiovascular Score (CCS score)
- Positive SPECT scan for myocardial ischemia
Exclusion
- Acute Coronary Syndrome 4 weeks before the coronary catheterization
- Percutaneous Coronary Angioplasty
- Coronary Artery Bypass Graft
- Active symptoms of allergy (asthma, urticaria)
- Mastocytosis
- Hypereosinophilia
- Autoimmune disease
- Cancer
- Kidney failure
- Myelodysplastic Syndrome
- Denial of signing informed consent
Key Trial Info
Start Date :
January 12 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 11 2027
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06958016
Start Date
January 12 2024
End Date
January 11 2027
Last Update
May 28 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
417 Military Hospital NIMTS
Athens, Attica, Greece, 11521
2
Larisa University Hospital
Larissa, Thessaly, Greece, 41334